Sotrovimab Sotrovimab is a monoclonal antibody that neutralizes sarbecoviruses (respiratory viruses detected by PCR on oral/nasal swabs or from bronchial/lung/respiratory tract specimens). This antibody was first isolated from a patient with SARS-CoV-1 (the virus responsible for the 2002-2004 SARS outbreak). Sotrovimab also works against SARS-CoV-2, which is responsible for the current COVID-19 pandemic. This antibody … Continue reading COMET-ICE Trial on Sotrovimab